Atlas Trials

How Important Are Hematological Parameters in the Prognosis of Severe Covid-19 Patients?

Clinical trial NCT05650944 · COMPLETED

Trial details

NCT number
NCT05650944
Sponsor
Hisar Intercontinental Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
COVID-19
Start date
2020-03-01
Primary completion
2021-12-31
Enrollment
125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.